Isolated distant lymph node metastases in ovarian cancer. Should a new substage be created?

por Nasioudis, Dimitrios, Ko, Emily M., Haggerty, Ashley F., Giuntoli, Robert L., Burger, Robert A., Morgan, Mark A., Latif, Nawar A.
Publicado 2019

Role of adjuvant chemotherapy in the management of stage IC ovarian granulosa cell tumors

por Nasioudis, Dimitrios, Ko, Emily M., Haggerty, Ashley F., Giuntoli, Robert L., Burger, Robert A., Morgan, Mark A., Latif, Nawar A.
Publicado 2019

Patterns of adjuvant treatment and survival outcomes in stage I uterine carcinosarcoma

por Cory, Lori, Brensinger, Colleen, Burger, Robert A., Giuntoli, Robert L., Morgan, Mark A., Latif, Nawar, Lin, Lilie L., Ko, Emily M.
Publicado 2022

Identification of Patients With Ovarian Cancer Experiencing the Highest Benefit From Bevacizumab in the First-Line Setting on the Basis of Their Tumor-Intrinsic Chemosensitivity (K...

por You, Benoit, Purdy, Christopher, Copeland, Larry J., Swisher, Elizabeth M., Bookman, Michael A., Fleming, Gini, Coleman, Robert, Randall, Leslie M., Tewari, Krishnansu S., Monk, Bradley J., Mannel, Robert S., Walker, Joan L., Cappuccini, Fabio, Cohn, David, Muzaffar, Mahvish, Mutch, David, Wahner-Hendrickson, Andrea, Martin, Lainie, Colomban, Olivier, Burger, Robert A.
Publicado 2022